Menu

Microbiome-Centric Human Health: A Call for Systems Biology

The Scientist is bringing together a panel of experts who will share their research, summarize the state of the science, and discuss the next steps in developing personalized microbiome-based therapies. 

Sep 6, 2017
The Scientist Creative Services Team

Microbiome-Centric Human Health: A Call for Systems Biology from thescientistllc on Vimeo.

With 100 times the number of genes contained in the human genome, and an array of different cell types and functions, one can argue that members of our microbiome constitute an additional human organ system. Research to date has implicated microbial activity in autoimmune disease, cancer, and the obesity epidemic. As a major source of variability across people, understanding and altering an individual’s microbiome is both a challenge and novel avenue for personalized medicine and nutrition. For a detailed look at the progress made toward understanding the host-microbiome interplay and the efforts undertaken to achieve a steady state of mutualism for a larger human health benefit, The Scientist is bringing together a panel of experts who will share their research, summarize the state of the science, and discuss the next steps in developing personalized microbiome-based therapies. Attendees will have the opportunity to interact with experts, ask questions, and seek advice on topics related to their research.

Topics to be covered:

  • Mechanisms by which human microbiota influence health and disease
  • How multidimensional data are being employed to develop personalized therapies

Meet the Speakers:

Eran Elinav, PhD
Professor, Department of Immunology
Weizmann Institute of Science, Israel

 

 

Eran Segal, PhD
Professor, Department of Mathematics and Computer Science
Weizmann Institute of Science, Israel

 

 

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!